Global Intussusception Market Projected to Grow at 4% CAGR, Reaching $5.46 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Intussusception Industry Market Size Be by 2025?
The market for intussusception has demonstrated consistent expansion over the preceding years, projected to increase its valuation from $4.45 billion in 2024 to $4.67 billion by 2025, reflecting a compound annual growth rate (CAGR) of 4.8%; this upward trajectory during the past era stems from advancements in diagnostic techniques, heightened public and professional knowledge, the expansion of worldwide medical facilities, increased funding directed towards R&D initiatives, and closer partnerships established between various healthcare organizations.

What's the Long-Term Growth Forecast for the Intussusception Market Size Through 2029?
Anticipating consistent upward movement, the intussusception market is projected to reach a value of $5.46 billion by the year 2029, exhibiting a steady compound annual growth rate of 4.0% throughout the forecast duration. This expansion is underpinned by several key factors, such as ongoing efforts in medical training, widespread pediatric immunization drives, worldwide attention dedicated to children's health, intensified attention on recovery following surgery, increasing need for research into pediatric digestive ailments, and greater availability of healthcare services via telemedicine platforms. Key developments characterizing this period involve progress in machinery for medical images, a shift towards less invasive treatment methods, creation of procedures tailored for younger patients, deeper investigation into the causes and factors contributing to the condition, undertaking worldwide studies of disease distribution, putting vaccination schemes into practice, and utilizing remote services for both identifying issues and providing medical advice.

View the full report here:
https://www.thebusinessresearchcompany.com/report/intussusception-global-market-report

What Are the Key Growth Drivers Fueling the Intussusception Market Expansion?
The growing prevalence of intestinal disorders is expected to drive the expansion of the intussusception market in the coming years. Intestinal disorders encompass medical conditions that disrupt the normal functioning of the intestines, which play a vital role in nutrient absorption and waste elimination. The increasing occurrence of conditions such as inflammatory bowel disease and gastrointestinal cancers contributes to earlier diagnosis, better treatment options, and improved care for individuals affected by intussusception, ultimately enhancing patient outcomes. For instance, in January 2023, the American Cancer Society (ACS), a US-based health organization focused on eliminating cancer, reported that cases of gastrointestinal cancers in the United States rose by 3.18% to 348,840 compared to 338,090 in 2021. Hence, the rising prevalence of intestinal disorders is fueling the growth of the intussusception market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13466&type=smp

What Are the Key Trends Driving Intussusception Market Growth?
Leading firms within the market segment focused on treating intestinal pseudo-obstruction are engaged in formulating innovative pharmacological interventions, notably utilizing NHE3 inhibitor treatments, with the goal of delivering dependable solutions to consumers. This NHE3 inhibitor therapy functions by obstructing the activity of the Sodium-Proton-Exchanger subtype 3 (NHE3) mechanism situated in the digestive tract. As an illustration, during April of 2022, Ardelyx Inc., a biopharmaceutical organization originating from the United States, launched IBSRELA, an NHE3 inhibitor designed for treating irritable bowel syndrome accompanied by constipation (IBS-C) in adult populations, which holds the potential to enhance gut movement. The mechanism of action for IBSRELA involves either suppressing or halting the function of the Sodium-Hydrogen Exchanger 3 (NHE3) protein. The endorsement of IBSRELA followed the successful completion of two studies conducted in Phase 3, involving more than 1,200 individuals afflicted with IBS-C, where the treatment demonstrated a significant enhancement in both instances of abdominal discomfort and defecation frequency, thereby achieving the main objective, with positive effects noted as early as the first week and maintaining consistency over a duration of 26 weeks throughout the extended trial period.

How Is the Intussusception Market Segmented?
The intussusceptionmarket covered in this report is segmented -

1) By Type: Idiopathic Intussusception; Secondary Intussusception
2) By Treatment: Enema Reduction; Surgery; Other Treatment
3) By Diagnosis: Barium Enema; Ultrasound; X-Ray; Computerized Tomography (CT)
4) By End-User: Hospitals; Clinics; Other End-User

Subsegments:
1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception; Adult Idiopathic Intussusception
2) By Secondary Intussusception: Neoplastic Intussusception; Infectious Intussusception; Inflammatory Intussusception; Post-Surgical Intussusception

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13466&type=smp

Which Companies Are Leading the Charge in Intussusception Market Innovation?
Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

Which Regions Are Leading the Global Intussusception Market in Revenue?
North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13466

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.